Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protectionVikas S. Sridhar, David Z.I. Cherney, Lisa Dubrofsky et al.|Brazilian Journal of Nephrology|2020Cited by 15